Monoamines in the pancreatic islets of the mouse. 5-hydroxytryptamine as an intracellular modifier of insulin secretion, and the hypoglycaemic action of monoamine oxidase inhibitors.
D006916:5-Hydroxytryptophan / Q000494:pharmacology; D000818:Animals; D001786:Blood Glucose; D003921:Diabetes Mellitus, Experimental; D005260:Female; D005947:Glucose / Q000494:pharmacology; D005905:Glyburide / Q000494:pharmacology; D006003:Glycogen / Q000032:analysis; D007003:Hypoglycemia / Q000139:chemically induced; D007328:Insulin / Q000097:blood; D007515:Islets of Langerhans / Q000378:metabolism*; D007545:Isoproterenol / Q000494:pharmacology; D051379:Mice; D008996:Monoamine Oxidase Inhibitors / Q000494:pharmacology*; D009526:Nialamide / Q000494:pharmacology; D010293:Pargyline / Q000494:pharmacology; D011292:Premedication; D012701:Serotonin / Q000502:physiology*
D001786:Blood Glucose; D007328:Insulin; D008996:Monoamine Oxidase Inhibitors; D012701:Serotonin; D006003:Glycogen; D010293:Pargyline; D006916:5-Hydroxytryptophan; D005947:Glucose; D007545:Isoproterenol; D005905:Glyburide; D009526:Nialamide